MONTREAL, QUEBEC--(Marketwire - June 9, 2009) - Thallion Pharmaceuticals Inc. (TSX:TLN - News) today announced the departure of Dr. Pierre Falardeau from the senior management team and Dr. Halvor Jaeger, F.C.P., from the Board of Directors. Dr. Falardeau has resigned his position as Chief Operating Officer of the Company, effective June 12, 2009, to pursue other interests and has agreed to act as a consultant to the Company to assist in the transition process.